Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vanta Bioscience Ltd has informed the BSE that its trading window for shares will be closed starting Wednesday, October 1, 2025, for all designated persons, their immediate relatives, and other concerned individuals. The closure is being done in line with the company's Insider Trading Code and SEBI's Prohibition of Insider Trading Regulations, 2015. The window will remain shut until 48 hours after the company declares its unaudited financial results for the half-year ending September 30, 2025. The board meeting date to approve these results will be communicated separately. The intimation was signed by CFO Venkata Sathya Murali Dokka on September 30, 2025.
This is a routine compliance announcement and signals that the company's half-yearly results are due soon, which may be relevant for investors tracking upcoming corporate actions. No direct impact on shareholders is expected from this notice itself.